Overview

Study To Evaluate Beta Cell Function and Glycemic Outcome by Intensive Insulin Therapy

Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
This randomized controlled prospective study aims to evaluate the efficacy of intensive insulin therapy for long term glycemic control and improvement or preservation of beta cell function in newly diagnosed type 2 diabetes patients.
Phase:
Phase 4
Details
Lead Sponsor:
Kyunghee University Medical Center
Collaborators:
Ajou University
East West Neo Medical Center
Hanyang University
Inha University Hospital
Jeju National University Hospital
Korea University Guro Hospital
Sanofi
The Catholic University of Korea
Treatments:
Glimepiride
Hypoglycemic Agents
Insulin
Insulin, Globin Zinc
Metformin